Yannick De Vlaeminck

Author

Vrije Universiteit Brussel ORCID

Also Known As

Julia Neumann, Y De Vlaeminck, Y. De Vlaeminck, Yannick De Vlaeminck

Publications

768

Citations

H-Index

Concepts

All Affiliations

Vrije Universiteit Brussel Universitair Ziekenhuis Brussel VIB-UGent Center for Inflammation Research Navarrabiomed VIB-VUB Laboratory Myeloid Cell Immunology

About

Yannick De Vlaeminck is an author at Vrije Universiteit Brussel specializing in immunology, medicine, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	37
2	Engineering	1	1	20
3	Allergy	1	1	15
4	Biomedical Engineering	1	1	20
5	Cell Biology	1	1	22

Yannick De Vlaeminck

Publications

358

Citations

H-Index

Page 1

	Year	Citations
<i>TUBA1A</i> mutations Anna Jansen, Ann Oostra, Brigitte Desprechins, Neurology	2011	69
Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use Quentin Lecocq, Katty Zeven, Yannick De Vlaeminck, Biomolecules	2019	53
Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade Quentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, Journal of Nuclear Medicine	2021	39
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development Yannick De Vlaeminck, Stefano Bonelli, Robin Maximilian Awad, Cancers	2020	32
Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells Inès Dufait, Julián Pardo, David Escors, Cancers	2019	27
Targeted α-Therapy Using<sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Journal of Nuclear Medicine	2023	25
Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages Yannick De Vlaeminck, Quentin Lecocq, Philippe Giron, Journal of Controlled Release Macrophage Mannose ReceptorImmunoengineeringImmunologyAntigen ProcessingFunctional Proteins	2019	22
Emerging applications of nanobodies in cancer therapy Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, International review of cell and molecular biology NanoparticlesNanomedicineCancer TherapyEngineeringTherapeutic Nanomaterials	2022	20
TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy Kirsten De Ridder, Hanne Locy, Elisa Piccioni, Frontiers in Immunology	2022	18
Antigen-presenting cell-targeted lentiviral vectors do not support the development of productive T-cell effector responses: implications for in vivo targeted vaccine delivery Cleo Goyvaerts, Yannick De Vlaeminck, David Escors, Gene Therapy VaccinationAllergyVaccine TargetImmunologyVaccine Delivery	2017	15

Page 1